Lack of Transforming Growth Factor-β1 Expression in Benign Skin Tumors of p53null Mice Is Prognostic for a High Risk of Malignant Conversion

Cancer Research

Volumn 54, Issue 22, 1994, Pages 5831-5836

  Kemp, Christopher J ^a   Balmain, Allan ^a   Akhurst, Rosemary J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; GENE DELETION; GENES, P53; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MICE, MUTANT STRAINS; PAPILLOMA; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028051817     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sporn, M.B. and Roberts, A.B. Autocrine growth factors and cancer. Nature (Lond.), 313: 745-747, 1985.
2. Masui, T. Wakefield, L.M. Lechner, J.F. La Veck, M.A. and Sporn, M.B. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA, 83: 2438-2442, 1986.
3. Shipley, G.D. Pittelkow, M.R. Wille, J.J.J. Scott, R.E. and Moses, H.L. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46: 2068-2071, 1986.
4. Coffey, R.J. Sipes, N.J. Bascom, C.C. Graves-Deal, R. Pennington, C.Y. Weissman, B.E. and Moses, H.L. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res. 48: 1596-1602, 1988.
5. Akhurst, R.J. Fee, F. and Balmain, A. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature (Lond.), 331: 363-365, 1988.
6. Krieg, P. Schnapke, R. Furstenberger, G. Vogt, I. and Marks, F. TGFΒ1 and skin carcinogenesis: antiproliferative effect in vitro and TGFΒ1 mRNA during epidermal hyperproliferation and multistage tumorigenesis. Mol. Carcinog. 4: 129-137, 1991.
7. Fowlis, D.J. Flanders, K. Duffie, E. Balmain, A. and Akhurst, R.J. Discordant TGFΒ1 RNA and protein localizations during chemical carcinogenesis of the skin. Cell Growth & Differ. 3: 81-91, 1992.
8. Esherick, J.S. DiCunto, F. Flanders, K.C. Missero, C. and Dotto, G.P. Transforming growth factor-β1 induction is associated with TGF β2 and β3 downmodulation in TPA-induced skin hyperplasia. Cancer Res. 53: 5517-5522, 1993.
9. Glick, A.B. Sporn, M.B. and Yuspa, S.H. Altered regulation of TGF-β1 and TGFα in primary keratinocytes and papillomas expressing v-Ha-ras. Mol. Carcinogen. 4: 210-219, 1991.
10. Glick, A.B. Kulkarni, A.B. Tennenbaum, T. Hennings, H. Flanders, K.C. O'Reilly, M. Sporn, M.B. Karlsson, S. and Yuspa, S.H. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA, 90: 6076-6080, 1993.
11. Jirtle, R.L. Haag, J.D. Ariazi, E.A. and Gould, M.N. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β, levels during monoterpene-induced regression of mammary tumors. Cancer Res. 53: 3849-3852, 1993.
12. Eklov, S. Funa, K. Nordgren, H. Olofsson, A. Kanzaki, T. Miyazono, K. and Nilsson, S. Lack of latent transforming growth factor β binding protein in malignant, but not benign prostatic tissue. Cancer Res. 53: 3193-3197, 1993.
13. Torre-Amione, G. Beauchamp, R.D. Koeppen, H. Park, B.H. Schreiber, H. Moses, H.L. and Rowley, D.A. A highly immunogenic tumor transfected with a murine transforming growth factor type β-1 cDNA escapes immune surveillance. Pro. Natl. Acad. Sci. USA, 87: 1486-1490, 1990.
14. Welch, D.R. Fabra, A. and Nakajima, M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA, 87: 7678-7682, 1990.
15. Gorsch, S.M. Memoli, V.A. Stukel, T.A. Gold, L.I. and Arrick, B.A. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res. 52: 6949-6952, 1992.
16. Haddow, S. Fowlis, D.J. Parkinson, K. Akhurst, R.J. and Balmain, A. Loss of growth control by TGFΒ occurs at a late stage of mouse carcinogenesis and is independent of ras gene activation. Oncogene, 6: 1465-1470, 1991.
17. Missero, C. Cajal, S.R.Y. and Dotto, G.P. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc. Natl. Acad. Sci. USA, 88: 9613-9617, 1991.
18. Manning, A.M. Williams, A.C. Games, S.M. and Paraskeva, C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene, 6: 1471-1476, 1991.
19. Terzaghi-Howe, M. Changes in response to, and production of, transforming growth factor type β during neoplastic progression in cultured rat tracheal epithelial cells. Carcinogenesis (Lond.), 10: 973-980, 1989.
20. Donehower, L.A. Harvey, M. Slagle, B.L. McArthur, M.J. Montgomery, C.A.J. Butel, J.S. and Bradley, A. Mice deficient for p. 3 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
21. Kemp, C.J. Donehower, L.A. Bradley, A. and Balmain, A. Reduction of p. 3 gene dosage does not increase initiation or promotion but greatly enhances malignant progression of chemically induced skin tumours. Cell, 74: 813-822, 1993.
22. Flanders, K.C. Thompson, N.L. Cissel, D.S. Van Obberghen, S.E. Baker, C.C. Kass, M.E. Ellingsworth, L.R. Roberts, A.B. and Sporn, M.B. Transforming growth factor-β 1: histochemical localization with antibodies to different epitopes. J. Cell Biol. 108: 653-660, 1989.
23. Scott, R.J. Hall, P.A. Haldane, J.S. Van Noorden, S. Price, Y. Lane, D.P. and Wright, N.A. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J. Pathol. 165: 173-178, 1991.
24. Hennings, H. Spangler, E.F. Shores, R. Mitchell, P. Devor, D. Shamsuddin, A.K.M. Elgjo, K.M. and Yuspa, S.H. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis (Lond.), 6: 1607-1610, 1985.
25. Rotello, R.J. Leiberman, R.C. Purchio, A.F. and Gerschenson, L.E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA, 88: 3412-3415, 1991.
26. Oberhammer, F.A. Pavelka, M. Sharma, S. Tiefenbacher, R. Purchio, A.F. Bursch, W. and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
27. Lin, J. and Chou, C. In vitro apoptosis in the human hepatoma cell line induced by trasnforming growth factor β1 Cancer Res. 52: 385-388, 1992.
28. Yanagihara, K. and Tsumuraya, M. Transforming growth factor β1, induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res. 52: 4042-4045, 1992.
29. Bursch, W. Oberhammer, F. Jirtle, R.L. Askari, M. Sedivy, R. Grasl-Kraupp, B. Purchio, A.F. and Schulte-Hermann, R. Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br. J. Cancer, 67: 531-536, 1993.
30. Shaw, P. Bovey, R. Sahli, R. Sordat, B. and Costa, J. Induction of apoptosis by wild-type p. 3 in human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
31. Clarke, A.R. Purdie, C.A. Harrison, D.J. Morris, R.G. Bird, C.C. Hooper, M.L. and Wyllie, A.H. Thymocyte apoptosis induced by p. 5-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
32. Burns, P.A. Kemp, C.J. Gannon, J.V. Lane, D.P. Bremner, R. and Balmain, A. Loss of heterozygosity and mutational analysis of the p. 3 gene in skin tumours of inter-specific hybrid mice. Oncogene, 6: 2363-2639, 1991.
33. Tennenbaum, T. Weiner, A.K. Belanger, A.J. Glick, A.B. Henning, H. and Yuspa, S.H. The suprabasal expression of α6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 53: 4803-4810, 1993.